190 related articles for article (PubMed ID: 12019580)
1. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature.
van Kuijk AA; Geurts AC; Bevaart BJ; van Limbeek J
J Rehabil Med; 2002 Mar; 34(2):51-61. PubMed ID: 12019580
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
[TBL] [Abstract][Full Text] [Related]
3. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
Ashford S; Turner-Stokes L
Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
Sheean G
Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
[TBL] [Abstract][Full Text] [Related]
10. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
Pennati GV; Da Re C; Messineo I; Bonaiuti D
Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin in stroke patients with severe upper limb spasticity.
Bhakta BB; Cozens JA; Bamford JM; Chamberlain MA
J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):30-5. PubMed ID: 8676154
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in poststroke spasticity.
Ozcakir S; Sivrioglu K
Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
[TBL] [Abstract][Full Text] [Related]
16. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
18. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.
Rosales RL; Kanovsky P; Fernandez HH
Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S3-10. PubMed ID: 21999894
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
[TBL] [Abstract][Full Text] [Related]
20. Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability.
Wolf SL; Milton SB; Reiss A; Easley KA; Shenvi NV; Clark PC
Arch Phys Med Rehabil; 2012 Apr; 93(4):578-87. PubMed ID: 22206630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
